Lassalle et al., 2008 - Google Patents
Fluorescence imaging of Foscan® and Foslip in the plasma membrane and in whole cellsLassalle et al., 2008
View HTML- Document ID
- 16036364145364599497
- Author
- Lassalle H
- Wagner M
- Bezdetnaya L
- Guillemin F
- Schneckenburger H
- Publication year
- Publication venue
- Journal of Photochemistry and Photobiology B: Biology
External Links
Snippet
A fluorescence microscope equipped with a condenser for total internal reflection (TIR) illumination was combined with a pulsed laser diode and a time-gated image intensifying camera for fluorescence lifetime measurements of single cells. In particular, fluorescence …
- 210000004027 cells 0 title abstract description 58
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
- G01N2021/653—Coherent methods [CARS]
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Khaydukov et al. | Riboflavin photoactivation by upconversion nanoparticles for cancer treatment | |
| Collins et al. | Blood-vessel closure using photosensitizers engineered for two-photon excitation | |
| König | Multiphoton microscopy in life sciences | |
| Karotki et al. | Simultaneous two‐photon excitation of photofrin in relation to photodynamic therapy | |
| AU716504B2 (en) | Method for improved selectivity in photo-activation and detection of molecular diagnostic agents | |
| Rück et al. | Fluorescence formation during photodynamic therapy in the nucleus of cells incubated with cationic and anionic water-soluble photosensitizers | |
| Dou et al. | Effective near-infrared photodynamic therapy assisted by upconversion nanoparticles conjugated with photosensitizers | |
| Jarvi et al. | Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy: current status, challenges and future prospects | |
| Kelbauskas et al. | Internalization of Aggregated Photosensitizers by Tumor Cells: Subcellular Time‐resolved Fluorescence Spectroscopy on Derivatives of Pyropheophorbide‐a Ethers and Chlorin e6 under Femtosecond One‐and Two‐photon Excitation¶ | |
| Kress et al. | Time-resolved microspectrofluorometry and fluorescence lifetime imaging of photosensitizers using picosecond pulsed diode lasers in laser scanning microscopes | |
| Sun et al. | Nitrogen-doped graphene quantum dots coupled with photosensitizers for one-/two-photon activated photodynamic therapy based on a FRET mechanism | |
| Lassalle et al. | Fluorescence imaging of Foscan® and Foslip in the plasma membrane and in whole cells | |
| Chen et al. | The binding characteristics and intracellular localization of temoporfin (mTHPC) in myeloid leukemia cells: Phototoxicity and mitochondrial damage¶ | |
| IL128355A (en) | Method and apparatus for improved selectivity in photo-activation of molecular agents | |
| Zhao et al. | Lysosome-targetable polythiophene nanoparticles for two-photon excitation photodynamic therapy and deep tissue imaging | |
| Ali-Seyed et al. | Photolon™-photosensitization induces apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes | |
| Sailer et al. | Relation between intracellular location and photodynamic efficacy of 5-aminolevulinic acid-induced protoporphyrin IXin vitro. Comparison between human glioblastoma cells and other cancer cell lines | |
| Gunduz et al. | Dual laser activatable brominated hemicyanine as a highly efficient and photostable multimodal phototherapy agent | |
| Scholz et al. | Imaging of singlet oxygen feedback delayed fluorescence and lysosome permeabilization in tumor in vivo during photodynamic therapy with aluminum phthalocyanine | |
| Beck et al. | Two-photon photodynamic therapy of C6 cells by means of 5-aminolevulinic acid induced protoporphyrin IX | |
| Überriegler et al. | Subcellular damage kinetics within co‐cultivated WI38 and VA13‐transformed WI38 human fibroblasts following 5‐aminolevulinic acid‐induced protoporphyrin IX formation | |
| Sasnouski et al. | Influence of incubation time and sensitizer localization on meta-tetra (hydroxyphenyl) chlorin (mTHPC)-induced photoinactivation of cells | |
| Haupt et al. | FRET energy transfer via Pdots improves the efficiency of photodynamic therapy and leads to rapid cell death | |
| Kamalov et al. | Selective effect of laser radiation on cancer cells and laser spectroscopyof the cell | |
| JP2003500094A (en) | Method and apparatus for multiphoton photoactivation and improved detection of molecular agents |